questionsmedicales.fr
Phénomènes physiologiques respiratoires et circulatoires
Phénomènes physiologiques respiratoires
Capacité pulmonaire totale
Capacité vitale
Capacité vitale : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Spirométrie
Fonction pulmonaire
Pléthysmographie
Gaz du sang
Capacité vitale
Normes physiologiques
Dyspnée
Maladies pulmonaires
Symptômes
5
Essoufflement
Oppression thoracique
Douleurs thoraciques
Cyanose
Âge
Dégradation pulmonaire
Prévention
5
Tabagisme
Activité physique
Vaccins
Infections respiratoires
Exercice physique
Fonction pulmonaire
Hydratation
Voies respiratoires
Traitements
5
Réhabilitation pulmonaire
Bronchodilatateurs
Physiothérapie
Fonction pulmonaire
Médicaments
Bronchodilatateurs
Complications
5
Insuffisance respiratoire
Infections pulmonaires
Capacité vitale
Complications respiratoires
Maladies cardiaques
Capacité vitale
Infections pulmonaires
Inflammation
Effets à long terme
Santé respiratoire
Facteurs de risque
5
Âge
Dégradation pulmonaire
Environnement de travail
Pollution
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Capacité vitale : Questions médicales les plus fréquentes",
"headline": "Capacité vitale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Capacité vitale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-22",
"dateModified": "2025-04-16",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Capacité vitale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Capacité pulmonaire totale",
"url": "https://questionsmedicales.fr/mesh/D014109",
"about": {
"@type": "MedicalCondition",
"name": "Capacité pulmonaire totale",
"code": {
"@type": "MedicalCode",
"code": "D014109",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G09.772.850"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Volume de réserve expiratoire",
"alternateName": "Expiratory Reserve Volume",
"url": "https://questionsmedicales.fr/mesh/D005105",
"about": {
"@type": "MedicalCondition",
"name": "Volume de réserve expiratoire",
"code": {
"@type": "MedicalCode",
"code": "D005105",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G09.772.850.970.360"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Capacité inspiratoire",
"alternateName": "Inspiratory Capacity",
"url": "https://questionsmedicales.fr/mesh/D007320",
"about": {
"@type": "MedicalCondition",
"name": "Capacité inspiratoire",
"code": {
"@type": "MedicalCode",
"code": "D007320",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G09.772.850.970.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Volume de réserve inspiratoire",
"alternateName": "Inspiratory Reserve Volume",
"url": "https://questionsmedicales.fr/mesh/D007321",
"about": {
"@type": "MedicalCondition",
"name": "Volume de réserve inspiratoire",
"code": {
"@type": "MedicalCode",
"code": "D007321",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G09.772.850.970.500.375"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Volume courant",
"alternateName": "Tidal Volume",
"url": "https://questionsmedicales.fr/mesh/D013990",
"about": {
"@type": "MedicalCondition",
"name": "Volume courant",
"code": {
"@type": "MedicalCode",
"code": "D013990",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G09.772.850.970.500.700"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Capacité vitale",
"alternateName": "Vital Capacity",
"code": {
"@type": "MedicalCode",
"code": "D014797",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Toby M Maher",
"url": "https://questionsmedicales.fr/author/Toby%20M%20Maher",
"affiliation": {
"@type": "Organization",
"name": "Keck School of Medicine, University of Southern California, Los Angeles, California, USA."
}
},
{
"@type": "Person",
"name": "Hyun Lee",
"url": "https://questionsmedicales.fr/author/Hyun%20Lee",
"affiliation": {
"@type": "Organization",
"name": "Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, South Korea."
}
},
{
"@type": "Person",
"name": "Hye Yun Park",
"url": "https://questionsmedicales.fr/author/Hye%20Yun%20Park",
"affiliation": {
"@type": "Organization",
"name": "Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea."
}
},
{
"@type": "Person",
"name": "Masato Kono",
"url": "https://questionsmedicales.fr/author/Masato%20Kono",
"affiliation": {
"@type": "Organization",
"name": "Department of Respiratory Medicine, Seirei Hamamatsu General Hospital, Hamamatsu, Japan. Electronic address: masato.k@sis.seirei.or.jp."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Multiple system atrophy.",
"datePublished": "2023-03-16",
"url": "https://questionsmedicales.fr/article/36927875",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/pn-2020-002797"
}
},
{
"@type": "ScholarlyArticle",
"name": "Multiple system atrophy.",
"datePublished": "2022-08-25",
"url": "https://questionsmedicales.fr/article/36008429",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41572-022-00382-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Inflammation in multiple system atrophy.",
"datePublished": "2023-06-22",
"url": "https://questionsmedicales.fr/article/37426656",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2023.1214677"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pathomechanisms of depression in multiple system atrophy.",
"datePublished": "2022-11-08",
"url": "https://questionsmedicales.fr/article/36348076",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00702-022-02560-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "The genetic basis of multiple system atrophy.",
"datePublished": "2023-02-10",
"url": "https://questionsmedicales.fr/article/36765380",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12967-023-03905-1"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes physiologiques respiratoires et circulatoires",
"item": "https://questionsmedicales.fr/mesh/D002943"
},
{
"@type": "ListItem",
"position": 3,
"name": "Phénomènes physiologiques respiratoires",
"item": "https://questionsmedicales.fr/mesh/D012143"
},
{
"@type": "ListItem",
"position": 4,
"name": "Capacité pulmonaire totale",
"item": "https://questionsmedicales.fr/mesh/D014109"
},
{
"@type": "ListItem",
"position": 5,
"name": "Capacité vitale",
"item": "https://questionsmedicales.fr/mesh/D014797"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Capacité vitale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Capacité vitale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Capacité vitale",
"description": "Comment évaluer la capacité vitale ?\nQuels tests complètent l'évaluation ?\nQuels sont les critères normaux de capacité vitale ?\nQuand suspecter une capacité vitale réduite ?\nQuels signes indiquent un problème pulmonaire ?",
"url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Multiple+System+Atrophy#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Capacité vitale",
"description": "Quels symptômes sont liés à une capacité vitale faible ?\nLa toux est-elle un symptôme associé ?\nComment la fatigue se manifeste-t-elle ?\nY a-t-il des signes d'alerte ?\nLes symptômes varient-ils selon l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Multiple+System+Atrophy#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Capacité vitale",
"description": "Comment prévenir la réduction de la capacité vitale ?\nLes vaccinations sont-elles importantes ?\nQuel rôle joue l'exercice physique ?\nFaut-il éviter certaines expositions ?\nL'hydratation est-elle importante ?",
"url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Multiple+System+Atrophy#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Capacité vitale",
"description": "Quels traitements améliorent la capacité vitale ?\nLa physiothérapie est-elle utile ?\nLes médicaments peuvent-ils aider ?\nQuand envisager une intervention chirurgicale ?\nLes traitements varient-ils selon la cause ?",
"url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Multiple+System+Atrophy#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Capacité vitale",
"description": "Quelles complications peuvent survenir ?\nLa capacité vitale faible augmente-t-elle les risques ?\nLes maladies cardiaques sont-elles liées ?\nComment les infections affectent-elles la capacité vitale ?\nY a-t-il des effets à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Multiple+System+Atrophy#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Capacité vitale",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il la capacité vitale ?\nLes maladies chroniques sont-elles un facteur ?\nLe sexe joue-t-il un rôle ?\nL'environnement de travail est-il un facteur ?",
"url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Multiple+System+Atrophy#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer la capacité vitale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "La capacité vitale est mesurée par spirométrie, un test de la fonction pulmonaire."
}
},
{
"@type": "Question",
"name": "Quels tests complètent l'évaluation ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests comme la pléthysmographie et les gaz du sang peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels sont les critères normaux de capacité vitale ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les valeurs normales varient selon l'âge, le sexe et la taille, généralement entre 3 et 6 L."
}
},
{
"@type": "Question",
"name": "Quand suspecter une capacité vitale réduite ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une capacité vitale réduite est suspectée en cas de dyspnée ou d'antécédents de maladies pulmonaires."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un problème pulmonaire ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme la toux persistante ou la fatigue peuvent indiquer une capacité vitale altérée."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une capacité vitale faible ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent essoufflement, fatigue, et sensation d'oppression thoracique."
}
},
{
"@type": "Question",
"name": "La toux est-elle un symptôme associé ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une toux persistante peut accompagner une capacité vitale diminuée."
}
},
{
"@type": "Question",
"name": "Comment la fatigue se manifeste-t-elle ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "La fatigue peut se manifester par une diminution de l'énergie et des difficultés à l'effort."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes d'alerte ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des douleurs thoraciques ou une cyanose nécessitent une attention médicale immédiate."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent être plus prononcés chez les personnes âgées en raison de la dégradation pulmonaire."
}
},
{
"@type": "Question",
"name": "Comment prévenir la réduction de la capacité vitale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabagisme, pratiquer une activité physique régulière et avoir une alimentation équilibrée."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccins contre la grippe et le pneumocoque aident à prévenir les infections respiratoires."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'exercice physique ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exercice régulier améliore la fonction pulmonaire et la capacité vitale."
}
},
{
"@type": "Question",
"name": "Faut-il éviter certaines expositions ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, éviter les polluants et les allergènes peut aider à préserver la santé pulmonaire."
}
},
{
"@type": "Question",
"name": "L'hydratation est-elle importante ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une bonne hydratation aide à maintenir la santé des voies respiratoires."
}
},
{
"@type": "Question",
"name": "Quels traitements améliorent la capacité vitale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la réhabilitation pulmonaire, les bronchodilatateurs et les corticostéroïdes."
}
},
{
"@type": "Question",
"name": "La physiothérapie est-elle utile ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la physiothérapie respiratoire aide à améliorer la capacité vitale et la fonction pulmonaire."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les bronchodilatateurs peuvent aider à ouvrir les voies respiratoires."
}
},
{
"@type": "Question",
"name": "Quand envisager une intervention chirurgicale ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une chirurgie peut être envisagée en cas de maladies pulmonaires graves, comme la BPCO."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon la cause ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le traitement dépend de la cause sous-jacente de la réduction de la capacité vitale."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent l'insuffisance respiratoire et des infections pulmonaires."
}
},
{
"@type": "Question",
"name": "La capacité vitale faible augmente-t-elle les risques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une capacité vitale faible augmente le risque de complications respiratoires graves."
}
},
{
"@type": "Question",
"name": "Les maladies cardiaques sont-elles liées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une capacité vitale réduite peut être associée à un risque accru de maladies cardiaques."
}
},
{
"@type": "Question",
"name": "Comment les infections affectent-elles la capacité vitale ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections pulmonaires peuvent réduire la capacité vitale en provoquant une inflammation."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets à long terme ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une capacité vitale réduite peut entraîner des effets à long terme sur la santé respiratoire."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent le tabagisme, l'exposition à des polluants et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il la capacité vitale ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la capacité vitale diminue généralement avec l'âge en raison de la dégradation pulmonaire."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques sont-elles un facteur ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme l'asthme ou la BPCO augmentent le risque de capacité vitale réduite."
}
},
{
"@type": "Question",
"name": "Le sexe joue-t-il un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les hommes ont généralement une capacité vitale plus élevée que les femmes en moyenne."
}
},
{
"@type": "Question",
"name": "L'environnement de travail est-il un facteur ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, travailler dans des environnements pollués ou dangereux peut affecter la capacité vitale."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 16/04/2025
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Publications dans "Capacité vitale" :
3 publications dans cette catégorie
Affiliations :
Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Imperial College London, London, UK.
Publications dans "Capacité vitale" :
3 publications dans cette catégorie
Affiliations :
Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, South Korea.
Publications dans "Capacité vitale" :
3 publications dans cette catégorie
Affiliations :
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Publications dans "Capacité vitale" :
3 publications dans cette catégorie
Affiliations :
Department of Respiratory Medicine, Seirei Hamamatsu General Hospital, Hamamatsu, Japan. Electronic address: masato.k@sis.seirei.or.jp.
Publications dans "Capacité vitale" :
3 publications dans cette catégorie
Affiliations :
Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Publications dans "Capacité vitale" :
3 publications dans cette catégorie
Affiliations :
Department of Respiratory Medicine, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
University of California San Francisco, 8785, San Francisco, California, United States.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Gerontology Department and Frailty in Ageing Research Department, Vrije Universiteit Brussel, Brussels, Belgium; Department of Geriatrics, Universitair Ziekenhuis Brussel, Brussels, Belgium. Electronic address: ivan.bautmans@vub.be.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Gerontology Department and Frailty in Ageing Research Department, Vrije Universiteit Brussel, Brussels, Belgium.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Ageing and Health Unit, WHO, Geneva, Switzerland.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Department of Human Movement Sciences, @AgeAmsterdam, Amsterdam Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, Netherlands; Department of Medicine and Aged Care, @AgeMelbourne, The University of Melbourne, The Royal Melbourne Hospital, Parkville, VIC, Australia; Yong Loo Lin School of Medicine, Centre for Healthy Longevity, National University of Singapore, Singapore; National University Health System, Singapore.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Institute for Biomedicine of Aging, University of Erlangen-Nuremberg, Nuremberg, Germany.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Centre de Recherche de l'Institut Universitaire de Gériatrie de Montréal, Montreal, QC, Canada; Faculty of Sciences, Department of Exercise Sciences, Université du Québec à Montréal, QC, Canada.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Firestone Institute for Respiratory Health, McMaster University, Hamilton, ON, Canada.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Center for Interstitial and Rare Lung Diseases, Pneumology and Respiratory Care Medicine, Thoraxklinik, University of Heidelberg, Member of the German Center for Lung Research, Heidelberg, Germany.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Weill Cornell Medicine, New York, New York, USA.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, South Korea.
Publications dans "Capacité vitale" :
This is a practical guide to diagnosing and managing multiple system atrophy (MSA). We explain the newly published Movement Disorders Society Consensus Diagnostic Criteria, which include new 'Clinical...
Multiple system atrophy (MSA) is a rare neurodegenerative disease that is characterized by neuronal loss and gliosis in multiple areas of the central nervous system including striatonigral, olivoponto...
Misfolding protein aggregation inside or outside cells is the major pathological hallmark of several neurodegenerative diseases. Among proteinopathies are neurodegenerative diseases with atypical Park...
Multiple system atrophy (MSA) is a rapidly progressing neurodegenerative disorder of uncertain etiology that is characterized by various combinations of Parkinsonism, autonomic, cerebellar and motor d...
Multiple system atrophy (MSA) is a heterogenous, uniformly fatal neurodegenerative ɑ-synucleinopathy. Patients present with varying degrees of dysautonomia, parkinsonism, cerebellar dysfunction, and c...
Despite the availability of the Unified Multiple System Atrophy (MSA) Rating Scale (UMSARS) for almost two decades, studies still use scales developed for Parkinson's disease (PD) or ataxia (ATX). Our...
A Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)-compliant literature search was conducted concerning studies of patients with MSA, reporting motor assessment with clinica...
We included 261 articles, of which 42.9% did not use UMSARS, but rather scales for PD (59.8%), ATX (24.1%), or both (14.3%). Although UMSARS use increased with time, misuse of PD and ATX scales persis...
Although higher in observational studies, the misuse of PD and ATX-related scales in MSA patients persists in prospective (planned) trials. Reasons for that must be addressed....
The aim of this study was to assess whether cancer occurs with increased frequency in multiple system atrophy (MSA). The pathological hallmark of MSA is glial cytoplasmic inclusions containing aggrega...
Medical records of 320 patients with pathologically confirmed MSA seen between 1998 and 2022 were reviewed. After excluding those with insufficient medical histories, the remaining 269 and an equal nu...
Of 269 cases in each group, 37 with MSA versus 45 of controls had a personal history of cancer. Reported cases of cancer in parents were 97 versus 104 and in siblings 31 versus 44 for MSA and controls...
The evidence from this retrospective cohort found no significant clinical association of MSA with breast cancer or other cancers. These results do not exclude the possibility that knowledge about synu...
Multiple system atrophy (MSA) is a rare, adult-onset, progressive neurodegenerative disorder with major diagnostic challenges. Aiming for a better diagnostic accuracy particularly at early disease sta...
To systematically evaluate structural MRI and diffusion MRI features for cross-sectional discrimination and tracking of longitudinal disease progression in early multiple system atrophy (MSA)....
In a prospective, longitudinal study of synucleinopathies with imaging on 14 controls and 29 MSA patients recruited at an early disease stage (15 predominant cerebellar ataxia subtype or MSA-C and 14 ...
We found that morphometric changes in the cerebellar white matter, brainstem, and pons can separate early MSA-C patients from controls both cross-sectionally and longitudinally (p < 0.01). The puta...
Regardless of clinically predominant features at the time of MSA assessment, brainstem and cerebellar pathways progressively deteriorate with disease progression. Quantitative measurements of these re...
Overlapping parkinsonism, cerebellar ataxia, and pyramidal signs render challenges in the clinical diagnosis of multiple system atrophy (MSA). The neuroimaging pattern is valuable to understand its pa...
We retrospectively obtained magnetic resonance imaging and susceptibility-weighted imaging in patients with MSA (including parkinsonian type [MSA-P] and cerebellar type [MSA-C]), Parkinson's disease, ...
Compared to controls, normalized putaminal volume significantly decreased in patients with MSA-P (P < .001) and normalized pontine volume significantly decreased in patients with MSA-C (P < .001). The...
The quantitative neuroimaging features and surface-based morphologic anomalies represent the markers of MSA and open new avenues for personalized clinical diagnosis....